Search Articles

View query in Help articles search

Search Results (1 to 1 of 1 Results)

Download search results: CSV END BibTex RIS


Use of mHealth Devices to Screen for Atrial Fibrillation: Cost-Effectiveness Analysis

Use of mHealth Devices to Screen for Atrial Fibrillation: Cost-Effectiveness Analysis

Costs, strokes, and fatal strokes classified on the basis of the CHA2 DS2-VASc score as well as the investigated group (N=30,000 patients per group per score). a ECG: electrocardiography. b CHA2 DS2-VASc: Congestive heart failure, Hypertension, Age≥75 years, Diabetes mellitus, Stroke, Vascular disease, Age 65-74 years, Sex category (female). c€1=US $1.12. d Total number of strokes includes nonfatal and fatal strokes. Summarized results of the simulations.

Godwin D Giebel

JMIR Mhealth Uhealth 2020;8(10):e20496